Page last updated: 2024-09-02

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Attention Deficit Disorder with Hyperactivity

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernardi, G; Castelli, M; Centonze, D; De Chiara, V; Federici, M; Gu, HH; Mercuri, NB; Motta, C; Musella, A; Napolitano, F; Romano, R; Rossi, S; Sacchetti, L; Siracusano, A; Studer, V; Usiello, A1

Other Studies

1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Attention Deficit Disorder with Hyperactivity

ArticleYear
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.
    The European journal of neuroscience, 2011, Volume: 34, Issue:9

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dronabinol; Excitatory Amino Acid Antagonists; Food Preferences; Gene Expression Regulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Point Mutation; Receptor, Cannabinoid, CB1; Receptors, GABA-B; Sucrose

2011